Ichinohe, Takeshi
The Institute of Medical Science, The University of Tokyo,
Japan
2025 Rank: 106057
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 399 out of 75944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106057 | 121318 |
| Total Cites | 398 | 412 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 171 | 172 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 316 | 324 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 361 | 367 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
3.40%
|
|
Ichinohe, Takeshi
The University of Tokyo,
Japan
2024 Rank: 163481
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 781 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 163481 | 176848 |
| Total Cites | 437 | 447 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 195 | 198 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 357 | 362 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 363 | 370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
2.24%
|
|
Ichinohe, Takeshi
The Institute of Medical Science, The University of Tokyo,
Japan
2023 Rank: 87829
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 464 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87829 | 102629 |
| Total Cites | 557 | 564 |
| H-index | 14 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 245 | 248 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 447 | 450 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 473 | 478 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.18 |
| Self-Citation Percentage |
1.24%
|
|
Ichinohe, Takeshi
The Institute of Medical Science, The University of Tokyo,
Japan
2022 Rank: 61603
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 387 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61603 | 69998 |
| Total Cites | 655 | 674 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 286 | 293 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 539 | 551 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 574 | 582 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
2.82%
|
|
Ichinohe, Takeshi
The University of Tokyo,
Japan
2021 Rank: 63235
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 348 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63235 | 73061 |
| Total Cites | 899 | 939 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 373 | 385 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 725 | 747 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 760 | 778 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
4.26%
|
|
Ichinohe, Takeshi
Institute of Medical Science The University of Tokyo,
Japan
2020 Rank: 150139
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 852 out of 58416 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150139 | 171141 |
| Total Cites | 448 | 480 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 260 | 273 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 351 | 371 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 362 | 376 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
6.67%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.